• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Compugen Ltd (NQ: CGEN )

    1.852 +0.032 (+1.74%)
    Streaming Delayed Price Updated: 12:17 PM EDT, Jul 23, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 47,692
    Open 1.820
    Bid (Size) 1.830 (12)
    Ask (Size) 1.840 (2)
    Prev. Close 1.820
    Today's Range 1.820 - 1.860
    52wk Range 0.5300 - 3.030
    Shares Outstanding 86,433,432
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    CGEN Stock Earnings: Compugen Misses EPS, Misses Revenue for Q1 2024
    CGEN stock results show that Compugen missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
    Via InvestorPlace
    CGEN Stock Earnings: Compugen Misses EPS, Beats Revenue for Q4 2023
    CGEN stock results show that Compugen missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. 
    Via InvestorPlace

    Performance

    YTD
    -7.18%
    -7.18%
    1 Month
    -0.98%
    -0.98%
    3 Month
    -2.03%
    -2.03%
    6 Month
    -0.45%
    -0.45%
    1 Year
    +65.33%
    +65.33%

    More News

    Read More
    Earnings Scheduled For March 5, 2024
    Via Benzinga
    Earnings Preview For Compugen
    Via Benzinga
    7 Speculative Stocks to Double Your Money THIS Year
    Via InvestorPlace
    Crude Oil Rises Over 1%; Biodexa Pharmaceuticals Shares Plunge
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    5 Analysts Have This to Say About Compugen
    Via Benzinga
    Compugen Earnings Preview
    Via Benzinga
    Expert Ratings for Compugen
    Via Benzinga
    Compugen: Q1 Earnings Insights
    Via Benzinga
    Dow Jumps 150 Points; FactSet Shares Rise After Q1 Results
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Compugen Ltd. (NASDAQ: CGEN) is One of Tuesday Morning’s Most Active Stocks
    Via Investor Brand Network
    Why Is Cancer Immunotherapy-Focused Compugen Stock Is Trading Higher Today?
    Via Benzinga
    Why Are Stocks Up Today?
    Via InvestorPlace
    Why Is Compugen (CGEN) Stock Up 189% Today?
    Via InvestorPlace
    US Stocks Higher; Accenture Issues Weak Sales Outlook
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    Gilead and Compugen Announce Exclusive License Agreement for Novel Pre-Clinical Immunotherapy Program
    From Gilead Sciences, Inc.
    Via Business Wire
    7 Promising Penny Stocks With the Potential to Defy Expectations
    Via InvestorPlace
    Use Support And Resistance Levels To Avoid Chaos In Your Portfolio
    Via Talk Markets
    Traders Insights: These Biotech Stocks On Radar: VSTM, SNTX, CGEN, SONN
    Via AB Newswire
    Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank
    Via Benzinga
    Why Compugen Shares Are Up Today
    Via The Motley Fool
    Earnings Scheduled For February 27, 2023
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.